Psychiatry and Neurology, Neurology · Quincy, IL
NPI
1043766314
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
927 Broadway St
Quincy, IL, 62301
Phone (217) 214-6240
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
1,561 services
Medicare patients, 2024
578
Average age 73
Drug cost, 2024
$413K
2,535 prescriptions
Company payments, 2025
$406
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmed Jouan was code 99232 (hospital e&m - subsequent), 496 times for 166 patients. In total Ahmed Jouan billed 1,561 services in 36 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 496 | 166 | $60.18 | $30K |
| 99214 Office E&M - Established | Facility | 268 | 217 | $69.48 | $19K |
| 99222 Hospital E&M - Initial | Facility | 199 | 189 | $97.62 | $19K |
| 99213 Office E&M - Established | Facility | 116 | 110 | $44.39 | $5,149 |
| 99205 Office E&M - New | Facility | 73 | 73 | $134.48 | $9,817 |
| 95717 Neurologic | Facility | 53 | 52 | $78.55 | $4,163 |
| 99231 Hospital E&M - Subsequent | Facility | 36 | 18 | $38.23 | $1,376 |
| 64615 Musculoskeletal | Facility | 32 | 11 | $91.79 | $2,937 |
| 95819 Neurologic | Facility | 31 | 31 | $42.61 | $1,321 |
| 95720 Neurologic | Facility | 28 | 16 | $157.65 | $4,414 |
| 95816 Neurologic | Facility | 27 | 27 | $42.68 | $1,152 |
| 99204 Office E&M - New | Facility | 26 | 26 | $103.12 | $2,681 |
| 95874 Musculoskeletal | Facility | 25 | 14 | $12.75 | $319 |
| 99223 Hospital E&M - Initial | Facility | 14 | 13 | $133.24 | $1,865 |
| 95718 Neurologic | Facility | 13 | 11 | $102.54 | $1,333 |
By year: 2022 $150K for 3,647 services; 2023 $142K for 1,954 services; 2024 $113K for 1,561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmed Jouan prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 295 prescriptions and refills. In total Ahmed Jouan wrote 2,535 Medicare prescriptions that cost $413K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 295 | 456 | 59 | $3,664 |
| Gabapentin Generic | 205 | 251 | 48 | $5,462 |
| Levetiracetam Generic | 194 | 323 | 40 | $5,270 |
| Primidone Generic | 172 | 254 | 36 | $3,588 |
| Donepezil Hcl Generic | 152 | 262 | 39 | $1,821 |
| Topiramate Generic | 125 | 184 | 27 | $914 |
| Memantine Hcl Generic | 115 | 176 | 25 | $3,303 |
| Zonisamide Generic | 97 | 131 | 19 | $1,917 |
| Lacosamide Generic | 77 | 91 | 13 | $7,859 |
| Aimovig Autoinjector Erenumab-Aooe | 75 | 83 | Under 11 | $60K |
| Ondansetron Hcl Generic | 65 | 65 | 18 | $709 |
| Duloxetine Hcl Generic | 57 | 85 | 13 | $2,458 |
| Nurtec Odt Rimegepant Sulfate | 56 | 56 | Under 11 | $72K |
| Lamotrigine Generic | 41 | 61 | Under 11 | $929 |
| Divalproex Sodium Generic | 41 | 43 | Under 11 | $1,220 |
Brand drugs: 202 claims; generic drugs: 2,317 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmed Jouan $406 ($406 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $82.39.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $82.39 |
| Lundbeck LLC | 2 | $42.97 |
| Merz Pharmaceuticals, LLC | 2 | $40.8 |
| Grifols USA, LLC | 2 | $38.64 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $32.43 |
| Lilly USA, LLC LLY | 1 | $25.25 |
| Argenx US, Inc. ARGX | 1 | $21.38 |
| Genentech USA, Inc. ROG.SW | 1 | $20.14 |
| Eisai Inc. 4523.T | 1 | $19.55 |
| Kyowa Kirin, Inc. 4151.T | 1 | $18.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.